Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
IRLCF Quote, Financials, Valuation and Earnings
Last price:
$275.00
Seasonality move
:
-1.26%
Day range:
$275.00 - $275.00
52-week range:
$219.00 - $578.00
Dividend yield:
0.73%
P/E ratio:
12.70x
P/S ratio:
0.30x
P/B ratio:
0.72x
Volume:
--
Avg. volume:
--
1-year change:
22.41%
Market cap:
$2.1B
Revenue:
$6.8B
EPS (TTM):
$21.65
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | $7B | $10B | $7.5B | $6.8B | |
| Revenue Growth (YoY) | -4.33% | 37.91% | 44% | -24.75% | -9.22% | |
| Cost of Revenues | $3.6B | $4.3B | $5B | $4.9B | $4.6B | |
| Gross Profit | $1.5B | $2.6B | $5B | $2.7B | $2.3B | |
| Gross Profit Margin | 29.45% | 37.47% | 50.2% | 35.39% | 32.92% | |
| R&D Expenses | $54M | $64M | $68M | $71M | $69M | |
| Selling, General & Admin | $731M | $1B | $1.1B | $1B | $1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.2B | $1.4B | $1.6B | $1.5B | $1.5B | |
| Operating Income | $265M | $1.2B | $3.5B | $1.2B | $765M | |
| Net Interest Expenses | $192M | $183M | $119M | $113M | $108M | |
| EBT. Incl. Unusual Items | -$34M | $1B | $3.3B | $962M | $631M | |
| Earnings of Discontinued Ops. | -$97M | -$181M | $50M | -- | -- | |
| Income Tax Expense | $25M | $260M | $1.2B | $287M | $157M | |
| Net Income to Company | -$156M | $562M | $2.2B | $675M | $474M | |
| Minority Interest in Earnings | -$17M | -$474M | -$1.3B | -$402M | -$284M | |
| Net Income to Common Excl Extra Items | -$173M | $88M | $953M | $273M | $190M | |
| Basic EPS (Cont. Ops) | -$22.69 | $11.54 | $124.96 | $35.80 | $25.30 | |
| Diluted EPS (Cont. Ops) | -$22.69 | $11.53 | $124.93 | $35.79 | $25.30 | |
| Weighted Average Basic Share | $7.6M | $7.6M | $7.6M | $7.6M | $7.5M | |
| Weighted Average Diluted Share | $7.6M | $7.6M | $7.6M | $7.6M | $7.5M | |
| EBITDA | $711M | $1.9B | $4.1B | $1.7B | $1.4B | |
| EBIT | $127M | $1.2B | $3.5B | $1.2B | $813M | |
| Revenue (Reported) | $5B | $7B | $10B | $7.5B | $6.8B | |
| Operating Income (Reported) | $265M | $1.2B | $3.5B | $1.2B | $765M | |
| Operating Income (Adjusted) | $127M | $1.2B | $3.5B | $1.2B | $813M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $2.5B | $2.1B | $1.7B | $1.8B | |
| Revenue Growth (YoY) | 14.48% | 67.22% | -16.2% | -18.01% | 1.84% | |
| Cost of Revenues | $1B | $1.3B | $1.3B | $1.2B | $1.2B | |
| Gross Profit | $494M | $1.2B | $845M | $556M | $559M | |
| Gross Profit Margin | 32.72% | 49.27% | 39.93% | 32.05% | 31.64% | |
| R&D Expenses | $15M | $18M | $18M | $17M | $18M | |
| Selling, General & Admin | $293M | $351M | $335M | $339M | $348M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $308M | $369M | $353M | $356M | $366M | |
| Operating Income | $186M | $875M | $492M | $200M | $193M | |
| Net Interest Expenses | $40M | $66M | $46M | $34M | $39M | |
| EBT. Incl. Unusual Items | $158M | $833M | $415M | $166M | $142M | |
| Earnings of Discontinued Ops. | -- | $39M | -- | -- | -- | |
| Income Tax Expense | $23M | $181M | $127M | $26M | $40M | |
| Net Income to Company | $135M | $691M | $288M | $140M | $102M | |
| Minority Interest in Earnings | -$80M | -$371M | -$171M | -$78M | -$67M | |
| Net Income to Common Excl Extra Items | $55M | $320M | $117M | $62M | $35M | |
| Basic EPS (Cont. Ops) | $7.21 | $41.96 | $15.33 | $8.22 | $4.67 | |
| Diluted EPS (Cont. Ops) | $7.21 | $41.93 | $15.33 | $8.22 | $4.67 | |
| Weighted Average Basic Share | $7.6M | $7.6M | $7.6M | $7.5M | $7.5M | |
| Weighted Average Diluted Share | $7.6M | $7.6M | $7.6M | $7.5M | $7.5M | |
| EBITDA | $381M | $1.1B | $662M | $392M | $376M | |
| EBIT | $263M | $944M | $531M | $244M | $224M | |
| Revenue (Reported) | $1.5B | $2.5B | $2.1B | $1.7B | $1.8B | |
| Operating Income (Reported) | $186M | $875M | $492M | $200M | $193M | |
| Operating Income (Adjusted) | $263M | $944M | $531M | $244M | $224M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.2B | $8B | $9.6B | $7.2B | $6.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.7B | $4.6B | $5B | $4.8B | $4.6B | |
| Gross Profit | $1.6B | $3.4B | $4.6B | $2.4B | $2.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $55M | $67M | $68M | $70M | $70M | |
| Selling, General & Admin | $770M | $1.1B | $1.1B | $1B | $1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.3B | $1.5B | $1.5B | $1.5B | $1.5B | |
| Operating Income | $320M | $1.9B | $3.1B | $894M | $758M | |
| Net Interest Expenses | $163M | $209M | $99M | $101M | $113M | |
| EBT. Incl. Unusual Items | $112M | $1.7B | $2.9B | $713M | $607M | |
| Earnings of Discontinued Ops. | -- | -$179M | $11M | -- | -- | |
| Income Tax Expense | $27M | $418M | $1.1B | $186M | $171M | |
| Net Income to Company | -$12M | $1.1B | $1.8B | $527M | $436M | |
| Minority Interest in Earnings | -$64M | -$765M | -$1.1B | -$309M | -$273M | |
| Net Income to Common Excl Extra Items | -$76M | $353M | $750M | $218M | $163M | |
| Basic EPS (Cont. Ops) | -$9.36 | $46.28 | $98.33 | $28.68 | $21.65 | |
| Diluted EPS (Cont. Ops) | -$9.36 | $46.24 | $98.28 | $28.68 | $21.65 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $909M | $2.7B | $3.7B | $1.4B | $1.4B | |
| EBIT | $326M | $2B | $3.1B | $878M | $793M | |
| Revenue (Reported) | $5.2B | $8B | $9.6B | $7.2B | $6.9B | |
| Operating Income (Reported) | $320M | $1.9B | $3.1B | $894M | $758M | |
| Operating Income (Adjusted) | $326M | $2B | $3.1B | $878M | $793M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $2.5B | $2.1B | $1.7B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $1.3B | $1.3B | $1.2B | $1.2B | |
| Gross Profit | $494M | $1.2B | $845M | $556M | $559M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $15M | $18M | $18M | $17M | $18M | |
| Selling, General & Admin | $293M | $351M | $335M | $339M | $348M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $308M | $369M | $353M | $356M | $366M | |
| Operating Income | $186M | $875M | $492M | $200M | $193M | |
| Net Interest Expenses | $40M | $66M | $46M | $34M | $39M | |
| EBT. Incl. Unusual Items | $158M | $833M | $415M | $166M | $142M | |
| Earnings of Discontinued Ops. | -- | $39M | -- | -- | -- | |
| Income Tax Expense | $23M | $181M | $127M | $26M | $40M | |
| Net Income to Company | $135M | $691M | $288M | $140M | $102M | |
| Minority Interest in Earnings | -$80M | -$371M | -$171M | -$78M | -$67M | |
| Net Income to Common Excl Extra Items | $55M | $320M | $117M | $62M | $35M | |
| Basic EPS (Cont. Ops) | $7.21 | $41.96 | $15.33 | $8.22 | $4.67 | |
| Diluted EPS (Cont. Ops) | $7.21 | $41.93 | $15.33 | $8.22 | $4.67 | |
| Weighted Average Basic Share | $7.6M | $7.6M | $7.6M | $7.5M | $7.5M | |
| Weighted Average Diluted Share | $7.6M | $7.6M | $7.6M | $7.5M | $7.5M | |
| EBITDA | $381M | $1.1B | $662M | $392M | $376M | |
| EBIT | $263M | $944M | $531M | $244M | $224M | |
| Revenue (Reported) | $1.5B | $2.5B | $2.1B | $1.7B | $1.8B | |
| Operating Income (Reported) | $186M | $875M | $492M | $200M | $193M | |
| Operating Income (Adjusted) | $263M | $944M | $531M | $244M | $224M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $618M | $508M | $762M | $537M | $618M | |
| Short Term Investments | $438M | $630M | $810M | $1B | $706M | |
| Accounts Receivable, Net | $883M | $1.4B | $1.6B | $1.4B | $1.3B | |
| Inventory | $1.3B | $1.6B | $2.1B | $1.7B | $1.6B | |
| Prepaid Expenses | $50M | $51M | $70M | $35M | $41M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.5B | $4.5B | $5.6B | $5B | $4.5B | |
| Property Plant And Equipment | $5.6B | $5.8B | $6B | $6.4B | $6.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $501M | $683M | $688M | $711M | $724M | |
| Other Intangibles | $364M | $378M | $357M | $354M | $335M | |
| Other Long-Term Assets | $162M | $170M | $82M | $104M | $110M | |
| Total Assets | $11.1B | $12.3B | $13.1B | $12.9B | $12.5B | |
| Accounts Payable | $740M | $1.1B | $1B | $912M | $1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $64M | $63M | $68M | $72M | $78M | |
| Other Current Liabilities | $160M | $204M | $281M | $192M | $189M | |
| Total Current Liabilities | $2.5B | $2.9B | $2.9B | $2.9B | $2.6B | |
| Long-Term Debt | $3.2B | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.3B | $8B | $7.2B | $6.5B | $6.1B | |
| Common Stock | $326M | $326M | $326M | $326M | $326M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.4B | $1.5B | $2.5B | $2.8B | $2.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.4B | $2.7B | $3.4B | $3.6B | $3.6B | |
| Total Equity | $3.8B | $4.3B | $5.9B | $6.4B | $6.4B | |
| Total Liabilities and Equity | $11.1B | $12.3B | $13.1B | $12.9B | $12.5B | |
| Cash and Short Terms | $1.1B | $1.1B | $1.6B | $1.6B | $1.3B | |
| Total Debt | $4.1B | $4.5B | $3.9B | $3.5B | $2.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $244M | $842M | $673M | $550M | $417M | |
| Short Term Investments | $463M | $561M | $1B | $912M | $797M | |
| Accounts Receivable, Net | $1.1B | $1.9B | $1.6B | $1.5B | $1.5B | |
| Inventory | $1.2B | $1.7B | $2.1B | $1.6B | $1.6B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.4B | $5.3B | $5.8B | $4.9B | $4.6B | |
| Property Plant And Equipment | $5.6B | $5.8B | $6.1B | $6.3B | $6.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $264M | $319M | $210M | $242M | $266M | |
| Total Assets | $10.9B | $13.2B | $13.3B | $12.8B | $12.9B | |
| Accounts Payable | $752M | $1.1B | $967M | $914M | $1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $754M | $1.1B | $1B | $866M | $959M | |
| Total Current Liabilities | $2.3B | $3B | $3B | $2.7B | $2.9B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.1B | $8B | $7.2B | $6.4B | $6.4B | |
| Common Stock | $326M | $326M | $326M | $326M | $326M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.4B | $3.2B | $3.5B | $3.6B | $3.6B | |
| Total Equity | $3.9B | $5.2B | $6.1B | $6.4B | $6.5B | |
| Total Liabilities and Equity | $10.9B | $13.2B | $13.3B | $12.8B | $12.9B | |
| Cash and Short Terms | $707M | $1.4B | $1.7B | $1.5B | $1.2B | |
| Total Debt | $4.2B | $4.5B | $4B | $3.4B | $3.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$156M | $562M | $2.2B | $675M | $474M | |
| Depreciation & Amoritzation | $584M | $750M | $539M | $540M | $614M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$82M | -$417M | -$262M | $278M | $65M | |
| Change in Inventories | $54M | -$267M | -$527M | $465M | -$7M | |
| Cash From Operations | $917M | $1.1B | $2.2B | $1.8B | $1.4B | |
| Capital Expenditures | $627M | $611M | $747M | $780M | $713M | |
| Cash Acquisitions | -$1M | -$326M | $15M | $6M | -$55M | |
| Cash From Investing | -$398M | -$830M | -$748M | -$1.1B | -$343M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$78M | -- | -$37M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $1.5B | $1.1B | $633M | $889M | |
| Long-Term Debt Repaid | -$1.4B | -$1.5B | -$1.6B | -$1.1B | -$1.4B | |
| Repurchase of Common Stock | -- | -- | -- | -$13M | -$20M | |
| Other Financing Activities | $12M | $18M | $241M | -$8M | -$12M | |
| Cash From Financing | -$192M | -$403M | -$1.2B | -$931M | -$979M | |
| Beginning Cash (CF) | $274M | $618M | $508M | $762M | $537M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $327M | -$125M | $300M | -$205M | $101M | |
| Ending Cash (CF) | $618M | $508M | $762M | $537M | $618M | |
| Levered Free Cash Flow | $290M | $497M | $1.5B | $1B | $710M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $135M | $691M | $288M | $140M | $102M | |
| Depreciation & Amoritzation | $118M | $123M | $131M | $148M | $152M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$156M | -$470M | -$41M | -$123M | -$217M | |
| Change in Inventories | $30M | -$87M | $51M | $51M | $28M | |
| Cash From Operations | $224M | $358M | $432M | $275M | $155M | |
| Capital Expenditures | $147M | $131M | $164M | $145M | $190M | |
| Cash Acquisitions | -$64M | $20M | $2M | -$7M | -$119M | |
| Cash From Investing | -$336M | -$53M | -$435M | -$3M | -$381M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $310M | $393M | $258M | $198M | $361M | |
| Long-Term Debt Repaid | -$496M | -$386M | -$255M | -$386M | -$397M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $16M | $237M | $7M | -- | -$2M | |
| Cash From Financing | -$263M | $23M | -$87M | -$254M | $18M | |
| Beginning Cash (CF) | $618M | $508M | $762M | $537M | $618M | |
| Foreign Exchange Rate Adjustment | $1M | $6M | $1M | -$5M | $7M | |
| Additions / Reductions | -$375M | $328M | -$90M | $18M | -$208M | |
| Ending Cash (CF) | $244M | $842M | $673M | $550M | $417M | |
| Levered Free Cash Flow | $77M | $227M | $268M | $130M | -$35M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$12M | $1.1B | $1.8B | $527M | $436M | |
| Depreciation & Amoritzation | $583M | $755M | $547M | $557M | $618M | |
| Stock-Based Compensation | -$3M | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$46M | -$731M | $167M | $196M | -$29M | |
| Change in Inventories | $56M | -$384M | -$389M | $465M | -$30M | |
| Cash From Operations | $966M | $1.2B | $2.3B | $1.7B | $1.3B | |
| Capital Expenditures | $635M | $595M | $780M | $761M | $758M | |
| Cash Acquisitions | -$38M | -$242M | -$3M | -$3M | -$167M | |
| Cash From Investing | -$739M | -$547M | -$1.1B | -$664M | -$721M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$78M | -- | -$37M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $1.5B | $960M | $573M | $1.1B | |
| Long-Term Debt Repaid | -$1.5B | -$1.4B | -$1.5B | -$1.2B | -$1.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $42M | $239M | $11M | -- | -$14M | |
| Cash From Financing | -$691M | -$117M | -$1.3B | -$1.1B | -$707M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$464M | $578M | -$118M | -$97M | -$125M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $331M | $647M | $1.5B | $904M | $545M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $135M | $691M | $288M | $140M | $102M | |
| Depreciation & Amoritzation | $118M | $123M | $131M | $148M | $152M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$156M | -$470M | -$41M | -$123M | -$217M | |
| Change in Inventories | $30M | -$87M | $51M | $51M | $28M | |
| Cash From Operations | $224M | $358M | $432M | $275M | $155M | |
| Capital Expenditures | $147M | $131M | $164M | $145M | $190M | |
| Cash Acquisitions | -$64M | $20M | $2M | -$7M | -$119M | |
| Cash From Investing | -$336M | -$53M | -$435M | -$3M | -$381M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $310M | $393M | $258M | $198M | $361M | |
| Long-Term Debt Repaid | -$496M | -$386M | -$255M | -$386M | -$397M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $16M | $237M | $7M | -- | -$2M | |
| Cash From Financing | -$263M | $23M | -$87M | -$254M | $18M | |
| Beginning Cash (CF) | $618M | $508M | $762M | $537M | $618M | |
| Foreign Exchange Rate Adjustment | $1M | $6M | $1M | -$5M | $7M | |
| Additions / Reductions | -$375M | $328M | -$90M | $18M | -$208M | |
| Ending Cash (CF) | $244M | $842M | $673M | $550M | $417M | |
| Levered Free Cash Flow | $77M | $227M | $268M | $130M | -$35M | |
Get IRLCF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IRLCF
Sector
P/E ratio
12.70x
16.29x
PEG ratio
--
0.00x
P/B ratio
0.72x
1.42x
Price / LTM sales
0.30x
1.42x
Growth Metrics
IRLCF
Sector
Revenue growth
1.84%
1.07%
Earnings growth
-43.19%
--
Revenue (5-year growth)
5.35%
3.71%
Earnings forecast
--
$0.04
Profitability
IRLCF
Sector
Profitability FY 2024
$2.3B
--
Return on invested capital
1.7%
1.75%
Return on assets
1.29%
1.06%
Return on equity
2.54%
2.52%
Earnings Date
Last Earnings Date
Jul
18
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Oct
17
Balance Sheet
IRLCF
Sector
Total cash
$1.2B
$2.4M
Short term investments
$706M
$326.7K
Total assets
$12.5B
$21.1M
Long term debt
$3.1B
$74M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
